CANF logo

Can-Fite BioPharma (CANF)

Profile

Full Name

Can-Fite BioPharma Ltd.

Ticker Symbol

CANF

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

November 6, 2012

Indexes

Not included

Website

http://www.canfite.com

Employees

8

Key Details

Price

$1.30(-17.20%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$743.00K(-8.27% YoY)

Annual EPS

-$3.00(0.00% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.30
CANF price is $1.30

30-Day Relative Volume

12.63
CANF 30-day relative volume is 12.63

Price Performance

Price Most recent change

-17.2%
CANF price was down -17.2% on Apr 14, 2025

Price YTD change

-20.25%
CANF price is down -20.25% since January 1st

Price 1-year change

-38.1%
CANF price is down -38.1% year-on-year

Price 3-year change

-88.39%
CANF price is down -88.39% over the past 3 years

Price Range

Price All-time high

$1419.00
CANF price is currently -99.91% below its historical high of $1419.00

Price 3-year low

$1.22
CANF price is currently +6.56% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$7.93M
CANF market capitalization is $7.93 million

Market cap 3-year change

-73.98%
CANF market capitalization is down -73.98% over the past 3 years

Market cap All-time high

$61.40M
CANF market capitalization is currently -87.09% below its historical high of $61.40 million

Market cap sector rank

16.94%
CANF market capitalization is higher than 16.94% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+22.16%
CANF shares outstanding is up +22.16% year-on-year

Shares Outstanding 3-Year Change

+124.2%
CANF shares outstanding is up +124.2% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.53
CANF beta is 0.53

200-day SMA

$2.08
CANF price is currently -37.53% below its 200-day simple moving average

50-day SMA

$1.56
CANF price is currently -16.66% below its 50-day simple moving average

RSI

40.37
CANF 14-day relative strength index is 40.37

Volume

12.63
CANF 30-day relative volume is 12.63

ATR

$0.17
CANF average true range is $0.17

10-day Historical Volatility

134.99%
CANF 10-day historical volatility is 134.99%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$743.00K
CANF annual revenue is $743.00 thousand

Revenue Analysts estimate

$500.00K
CANF annual revenue is currently +48.60% higher than the consensus analysts' forecast

Revenue 1-year change

-8.27%
CANF annual revenue is down -8.27% year-on-year

Revenue Sector rank

11.31%
CANF annual revenue is higher than 11.31% of companies in Healthcare sector

EPS

EPS

-$3.00
CANF annual earnings per share is -$3.00

EPS Analysts estimate

-
CANF annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

0%
CANF {parameterFullLabel} has remained unchanged year-on-year

EPS Sector rank

29.64%
CANF annual earnings per share is higher than 29.64% of companies in Healthcare sector

Profit

Gross profit

-
CANF annual gross profit value is unknown

Gross margin

-
CANF annual gross profit margin value is unknown

Operating profit

-$8.20M
CANF annual operating income is -$8.20 million

Operating margin

-1102.96%
CANF annual operating profit margin is -1102.96%

Net income

-$7.63M
CANF annual net profit is -$7.63 million

Net margin

-1027.46%
CANF annual net profit margin is -1027.46%

Expenses

Total expenses

$8.94M
CANF annual total expenses is $8.94 million

Operating expenses

$8.94M
CANF annual total operating expenses is $8.94 million

Cost of goods sold

-
CANF annual cost of goods sold value is unknown

Selling, general & administrative expenses

$2.96M
CANF annual SGA is $2.96 million

Depreciation and amortization

$15.00K
CANF annual depreciation & amortization is $15.00 thousand

Interest expense

-
CANF annual interest expense value is unknown

Income tax

$0.00
CANF annual income tax is $0.00

EBIT & EBITDA

EBIT

-$8.20M
CANF annual earnings before interest & taxes is -$8.20 million

EBITDA

-$8.18M
CANF annual EBITDA is -$8.18 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.99M
CANF annual total assets is $9.99 million

Non current assets

$81.00K
CANF annual long term assets is $81.00 thousand

Current assets

$9.91M
CANF annual total current assets is $9.91 million

Cash and cash equivalents

$4.28M
CANF annual cash & cash equivalents is $4.28 million

Accounts receivable

-
CANF annual accounts receivable value is unknown

Inventory

-
CANF annual inventory value is unknown

Liabilities

Total liabilities

$3.75M
CANF annual total liabilities is $3.75 million

Long term liabilities

$1.73M
CANF annual total long term liabilities is $1.73 million

Current liabilities

$2.02M
CANF annual total current liabilities is $2.02 million

Accounts payable

$427.00K
CANF annual accounts payable is $427.00 thousand

Debt

Total debt

$40.00K
CANF annual total debt is $40.00 thousand

Total debt 1-year change

-35.48%
CANF annual total debt is down -35.48% year-on-year

Long term debt

$13.00K
CANF annual long term debt is $13.00 thousand

Short term debt

$27.00K
CANF annual short term debt is $27.00 thousand

Equity & Capital

Shareholders equity

$6.24M
CANF annual stockholders equity is $6.24 million

Book value

$6.24M
CANF annual book value is $6.24 million

Retained earnings

-$158.48M
CANF annual retained earnings is -$158.48 million

Working capital

$7.89M
CANF annual working capital is $7.89 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.44M
CANF annual cash flow from operations is -$8.44 million

Cash from operations 1-year change

+21.86%
CANF annual cash flow from operations is up +21.86% year-on-year

Cash from investing

$498.00K
CANF annual cash flow from investing activities is $498.00 thousand

Cash from investing 1-year change

-94.76%
CANF annual cash flow from investing activities is down -94.76% year-on-year

Cash from financing

$9.14M
CANF annual cash flow from financing activities is $9.14 million

Cash from financing 1-year change

+100%
CANF annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

$2000.00
CANF annual capital expenditures is $2000.00

CAPEX 1-year change

-77.78%
CANF annual capital expenditures is down -77.78% year-on-year

Free Cash Flow

Free cash flow

-$8.44M
CANF annual free cash flow is -$8.44 million

Free cash flow 1-year change

+21.91%
CANF annual free cash flow is up +21.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CANF annual gross profit margin value is unknown

Operating margin

-1102.96%
CANF annual operating profit margin is -1102.96%

Net margin

-1027.46%
CANF annual net profit margin is -1027.46%

ROA & ROE

ROA

-79.22%
CANF annual return on assets is -79.22%

ROE

-142.49%
CANF annual return on equity is -142.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CANF price to earnings ratio value is unknown

PE ratio Sector rank

-
CANF price to earnings ratio is unknown

PB Ratio

PB ratio

3.20
CANF price to book ratio is 3.20

PB ratio Sector rank

73.33%
CANF price to book ratio is higher than 73.33% of companies in Healthcare sector

PS Ratio

PS ratio

-
CANF price to sales ratio value is unknown

PS ratio Sector rank

-
CANF price to sales ratio is unknown

Enterprise value

Enterprise value

$3.26M
CANF enterprise value is $3.26 million

Enterprise value Sector rank

16.69%
CANF enterprise value is higher than 16.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
CANF EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
CANF EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.91
CANF annual current ratio is 4.91

Quick ratio

-
CANF annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CANF annual debt to equity ratio is 0.00

Interest coverage ratio

-
CANF annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CANF piotroski f-score value is unknown

Altman Z-Score

-22.63
CANF altman z-score is -22.63

Analyst ratings

Recent major analysts updates

Mar 21, 25 D. Boral Capital
Buy
Mar 20, 25 D. Boral Capital
Buy
Mar 18, 25 D. Boral Capital
Buy
Mar 3, 25 D. Boral Capital
Buy
Feb 18, 25 D. Boral Capital
Buy
Dec 31, 24 D. Boral Capital
Buy
Dec 5, 24 D. Boral Capital
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Jul 17, 24 EF Hutton
Buy
May 9, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Scienture Holdings (SCNX)
COSM logo
Cosmos Health (COSM)
CHRO logo
Channel Therapeutics (CHRO)
OSA logo
ProSomnus (OSA)
PMCB logo
PharmaCyte Biotech (PMCB)
CDT logo
Conduit Pharmaceuticals (CDT)
MHUA logo
Meihua International Medical Technologies Co (MHUA)
MYNZ logo
Mainz Biomed BV (MYNZ)
PRPO logo
Precipio (PRPO)
  • What is the ticker symbol for Can-Fite BioPharma?
  • Does Can-Fite BioPharma pay dividends?
  • What sector is Can-Fite BioPharma in?
  • What industry is Can-Fite BioPharma in?
  • What country is Can-Fite BioPharma based in?
  • When did Can-Fite BioPharma go public?
  • Is Can-Fite BioPharma in the S&P 500?
  • Is Can-Fite BioPharma in the NASDAQ 100?
  • Is Can-Fite BioPharma in the Dow Jones?
  • When was Can-Fite BioPharma's last earnings report?
  • When does Can-Fite BioPharma report earnings?
  • Should I buy Can-Fite BioPharma stock now?

What is the ticker symbol for Can-Fite BioPharma?

The ticker symbol for Can-Fite BioPharma is NYSE American:CANF

Does Can-Fite BioPharma pay dividends?

No, Can-Fite BioPharma does not pay dividends

What sector is Can-Fite BioPharma in?

Can-Fite BioPharma is in the Healthcare sector

What industry is Can-Fite BioPharma in?

Can-Fite BioPharma is in the Biotechnology industry

What country is Can-Fite BioPharma based in?

Can-Fite BioPharma is headquartered in Israel

When did Can-Fite BioPharma go public?

Can-Fite BioPharma's initial public offering (IPO) was on November 6, 2012

Is Can-Fite BioPharma in the S&P 500?

No, Can-Fite BioPharma is not included in the S&P 500 index

Is Can-Fite BioPharma in the NASDAQ 100?

No, Can-Fite BioPharma is not included in the NASDAQ 100 index

Is Can-Fite BioPharma in the Dow Jones?

No, Can-Fite BioPharma is not included in the Dow Jones index

When was Can-Fite BioPharma's last earnings report?

Can-Fite BioPharma's most recent earnings report was on Aug 29, 2024

When does Can-Fite BioPharma report earnings?

The next expected earnings date for Can-Fite BioPharma is May 15, 2025

Should I buy Can-Fite BioPharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page